Holen Sie sich die Stockscreener-App
23.52
0.34%
-0.08
Handel nachbörslich:
24.78
1.26
+5.36%
Schlusskurs vom Vortag:
$23.60
Offen:
$23.41
24-Stunden-Volumen:
2.46M
Relative Volume:
1.20
Marktkapitalisierung:
$2.89B
Einnahmen:
$643.81M
Nettoeinkommen (Verlust:
$-490.76M
KGV:
-5.7931
EPS:
-4.06
Netto-Cashflow:
$-299.27M
1W Leistung:
+7.94%
1M Leistung:
+6.14%
6M Leistung:
+24.58%
1J Leistung:
-17.96%
1-Tages-Spanne:
$23.27
$24.10
1-Wochen-Bereich:
$21.28
$24.32
52-Wochen-Spanne:
$15.81
$37.04
Guardant Health Inc Stock (GH) Company Profile
Firmenname
Guardant Health Inc
Sektor
Branche
Telefon
855-698-8887
Adresse
3100 HANOVER STREET, PALO ALTO
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-14 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-27 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-26 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-03-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-11-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-06 | Eingeleitet | Stephens | Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-28 | Fortgesetzt | BTIG Research | Buy |
| 2022-02-24 | Bestätigt | Canaccord Genuity | Buy |
| 2022-02-24 | Bestätigt | Citigroup | Buy |
| 2022-02-24 | Bestätigt | Cowen | Outperform |
| 2022-02-24 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-24 | Bestätigt | SVB Leerink | Outperform |
| 2022-02-24 | Bestätigt | Stifel | Buy |
| 2022-02-24 | Bestätigt | Wells Fargo | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-11 | Eingeleitet | Stifel | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-06-12 | Eingeleitet | BTIG Research | Buy |
| 2020-02-21 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-08-07 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-04-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | Bestätigt | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-29 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Guardant Health Inc Aktie (GH) Neueste Nachrichten
Unveiling Guardant Health (GH) Q3 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance
Guardant Health Inc (GH) Shares Up 5.61% on Nov 4 - GuruFocus.com
abrdn plc Raises Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
How To Trade (GH) - Stock Traders Daily
Guardant Health to Participate in Upcoming Investor Conferences - StockTitan
Guardant Health (GH) Stock Surges on Innovative Product Recognition - GuruFocus.com
Why Guardant Health Stock Was the Picture of Health Today - MSN
Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Guardant Health Named to TIME’s List of the Best Inventions of 2024 - The Bakersfield Californian
Guardant Health (GH) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Guardant Health (NASDAQ:GH) Trading Up 6.4%What's Next? - MarketBeat
GHGuardant Health, Inc. Latest Stock News & Market Updates - StockTitan
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024 - Business Wire
Companion Diagnostics Market to Enjoy 'Explosive Growth' to 2032| Biogenex Laboratories, Guardant Health, Abnova - openPR
Liquid Biopsy Market Size, Share, Growth Insights and Report - openPR
Guardant Health, Inc. (NASDAQ:GH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
An Intrinsic Calculation For Guardant Health, Inc. (NASDAQ:GH) Suggests It's 44% Undervalued - Simply Wall St
Guardant Health names new board member - Investing.com India
Where Does Wall Street Think Guardant Health Inc (GH) Stock Will Go? - InvestorsObserver
Roberto A. Mignone Joins Guardant Health Board of Directors - 01Net
Guardant Health names new board member By Investing.com - Investing.com UK
Guardant Health, Inc. Appoints Roberto Mignone. as Class I Director - Marketscreener.com
(GH) Trading Signals - Stock Traders Daily
Is There An Opportunity With Guardant Health, Inc.'s (NASDAQ:GH) 43% Undervaluation? - Yahoo Finance
Guardant Health (GH) Shares Decline Amid Market Volatility - GuruFocus.com
Guardant Health Inc (GH) Stock Price Down 3.84% on Oct 17 - GuruFocus.com
Leerink Partners Cuts Guardant Health (NASDAQ:GH) Price Target to $50.00 - MarketBeat
Can This Beaten-Down Cathie Wood Stock Bounce Back? - The Motley Fool
Quinn Emanuel client sanctioned over expert testimony - Daily Journal
Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024 - BioSpace
Short Interest in Guardant Health, Inc. (NASDAQ:GH) Rises By 20.6% - MarketBeat
4 Cancer Stocks to Consider in 2024 - The Motley Fool
Learn to Evaluate (GH) using the Charts - Stock Traders Daily
SG Americas Securities LLC Invests $1.03 Million in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Quinn Emanuel concedes expert's errors, says punishment unwarranted - Daily Journal
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market 2024: - openPR
Guardant Health Enters Oversold Territory (GH) - Nasdaq
Behind the Bell: Guardant Health - Nasdaq
Sei Investments Co. Takes $831,000 Position in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Deep Track Capital, LP Increases Stake in Guardant Health Inc - GuruFocus.com
45,267 Shares in Guardant Health, Inc. (NASDAQ:GH) Acquired by Thrivent Financial for Lutherans - MarketBeat
Lawyers say opponents are lying, judge calls one a fool in DNA test dispute - Daily Journal
Guardant Health, Inc. (NASDAQ:GH) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients - Nature.com
(GH) Long Term Investment Analysis - Stock Traders Daily
FDA approves first blood test screening for colon cancer - MSN
Canada Pension Plan Investment Board Invests $303,000 in Guardant Health, Inc. (NASDAQ:GH) - Defense World
Guardant Health’s stock up after FDA approves its blood test for colon-cancer screening - MSN
Scientech Research LLC Buys New Shares in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
7,652 Shares in Guardant Health, Inc. (NASDAQ:GH) Bought by Commonwealth Equity Services LLC - Defense World
Finanzdaten der Guardant Health Inc-Aktie (GH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.48%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):